ACCELERATE DIAGNOSTICS INC (AXDX)
US00430H2013 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 12.14M | 34.90M | 39.90M | 35.80M | 61.00M | |||
| Marketable Securities | 1.08M | 10.70M | 23.70M | 32.50M | 47.40M | |||
| Receivables | 2.62M | 2.40M | 2.30M | 1.60M | 3.20M | |||
| Inventories | 3.31M | 5.20M | 5.10M | 9.20M | 8.10M | |||
| Other Current Assets | 5.31M | 2.80M | 2.40M | 3.00M | 2.20M | |||
| Total Current Assets | 24.47M | 56.00M | 73.30M | 82.00M | 121.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.08M | 7.80M | 7.90M | 9.30M | 11.80M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 1.82M | 1.20M | 1.80M | 2.10M | 800.00K | |||
| Total Non-Current Assets | 6.90M | 9.00M | 9.70M | 11.40M | 12.50M | |||
| TOTAL ASSETS | 31.37M | 65.00M | 83.00M | 93.40M | 134.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.31M | 57.50M | 100.00K | 600.00K | N/A | |||
| Accrued Expenses | 4.38M | 4.00M | 4.40M | 4.80M | 5.50M | |||
| Accounts Payable | 4.80M | 4.50M | 2.00M | 1.30M | 2.40M | |||
| Other Current Liabilities | 1.54M | 500.00K | 500.00K | 400.00K | 300.00K | |||
| Total Current Liabilities | 12.03M | 66.60M | 6.90M | 7.00M | 8.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 36.36M | 17.60M | 108.00M | 145.90M | 130.00M | |||
| Other Non-Current Liabilities | 2.86M | 3.10M | 3.20M | 3.40M | 3.60M | |||
| Total Non-Current Liabilities | 39.22M | 20.70M | 111.20M | 149.20M | 133.60M | |||
| TOTAL LIABILITIES | 51.25M | 87.30M | 118.10M | 156.20M | 141.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -668.86M | -607.20M | -570.70M | -493.00M | -414.70M | |||
| Additional Paid In Capital | 694.63M | 630.30M | 580.70M | 475.10M | 452.30M | |||
| Common Shares | 14.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | -45.07M | -45.10M | -45.10M | -45.10M | -45.10M | |||
| Other Shareholders' Equity | -612.00K | -400.00K | -100.00K | 100.00K | -100.00K | |||
| Shares Outstanding | 14.57M | 9.70M | 6.80M | 5.80M | 5.50M | |||
| Tangible Book Value per Share | -1.37 | -2.30 | -5.16 | -10.83 | -1.35 | |||
| Total Shareholders' Equity | -19.89M | -22.30M | -35.10M | -62.80M | -7.40M | |||
| TOTAL LIABILITIES AND EQUITY | 31.37M | 65.00M | 83.00M | 93.40M | 134.40M | |||
| Statistics | ||||||||
| Debt/Equity | -1.83 | -0.79 | -3.08 | -2.32 | -17.57 | |||
| Current Ratio | 2.03 | 0.84 | 10.62 | 11.71 | 14.87 | |||
| Return On Assets (ROA) | -196.45% | -96.14% | -93.61% | -83.74% | -62.73% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD